François Spertini
University Hospital of Lausanne(CH)University of Lausanne(CH)
Publications by Year
Research Areas
Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research, Monoclonal and Polyclonal Antibodies Research, Systemic Sclerosis and Related Diseases
Most-Cited Works
- → Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance(2019)2,170 cited
- → Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease(2018)286 cited
- → Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial(1998)222 cited
- → New therapeutic perspectives to manage refractory immune checkpoint-related toxicities(2019)184 cited
- → Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial(2015)174 cited
- → Elevated serum levels of free interleukin-18 in adult-onset Still’s disease(2016)168 cited